Genmab A/S
COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS
Last updated:
Abstract:
The invention relates to novel method for the treatment of cancer using a combination therapy comprising an antibody that binds CD38, a corticosteroid and a non-corticosteroid chemotherapeutic agent.
Status:
Application
Type:
Utility
Filling date:
12 Sep 2019
Issue date:
16 Apr 2020